Johnson & Johnson (JNJ) Stock Forecast & Price Target

JNJ$280.41-0.37 -0.13%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$675.03BEnterprise value$692.93BRevenue (TTM)$99.33BMarket positionTop 5%

Score

38
Bearish
Value
18
Quality
69
Growth
26

Johnson & Johnson price target

JNJ
Low$260.00
Average$285.31
High$320.00
Upside vs current price+1.7%

The average target of $285.31 is +1.7% versus the current JNJ price of $280.41.

Johnson & Johnson analyst ratings

RatingAnalysts
Strong buy5
Buy11
Hold6
Sell1
Strong sell0
ConsensusBuy

23 analysts cover JNJ.

Johnson & Johnson EPS and revenue estimates

The estimate table for the Johnson & Johnson keeps 2026 EPS $11.11, 2027 EPS $11.60, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$11.11$101.21B
2027$11.60$107.88B

Is Johnson & Johnson a buy or sell?

Of the 23 analysts covering Johnson & Johnson, 16 rate it a buy (5 strong buy and 11 buy), 6 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).

The JNJ consensus label is Buy, beside 16 buy-side ratings and 1 sell-side ratings.

The average target of $285.31 implies +1.7% versus the current price of $280.41.

the Johnson & Johnson closes with 16 buy-side ratings and 1 on the sell side. The headcount is Buy.

Reading the Johnson & Johnson forecast

Between the JNJ low of $260.00 and the high of $320.00, the average target is $285.31.

From today's $280.41 print, the JNJ average target is +1.7% away.

Most of the JNJ coverage agrees: 16 of 23 analysts are on the buy side, 6 are at hold, and 1 is on the sell side, and the published consensus is Buy.

JNJ targets have eased: $280.50 in the last month against $287.42 over the last quarter.

Coverage of JNJ is broad at 23 analysts, and the average is a crowd rather than a single desk.

Johnson & Johnson forecast questions

What is the JNJ price target?

The published range for JNJ is $260.00 to $320.00, with an average of $285.31. That average is +1.7% versus the current price of $280.41.

Is Johnson & Johnson a buy or sell?

Of the 23 analysts covering Johnson & Johnson, 16 rate it a buy, 6 rate it a hold, and 1 rates it a sell. The consensus is Buy, which for JNJ is 16 on the buy side, 6 at hold, and 1 on the sell side.

What is the EPS estimate for Johnson & Johnson?

Analyst EPS estimates for Johnson & Johnson: 2026 $11.11, 2027 $11.60.

What is the revenue estimate for Johnson & Johnson?

Analyst revenue estimates for Johnson & Johnson: 2026 $101.21B, 2027 $107.88B.

How many analysts cover JNJ?

23 analysts cover JNJ. Their consensus on JNJ is Buy, across those 23.

JNJ price $280.41 -0.37 -0.13%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener